These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30511123)

  • 21. An update on the topical and oral therapy options for treating pediatric atopic dermatitis.
    Glines KR; Stiff KM; Freeze M; Cline A; Strowd LC; Feldman SR
    Expert Opin Pharmacother; 2019 Apr; 20(5):621-629. PubMed ID: 30601075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of atopic dermatitis patients using complementary and alternative medicine: A literature review.
    Delhomme C; Adam T; Seiller H; Bursztejn AC
    Ann Dermatol Venereol; 2024 Mar; 151(1):103257. PubMed ID: 38489869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pimecrolimus: a review of its use in atopic dermatitis.
    Wellington K; Noble S
    Am J Clin Dermatol; 2004; 5(6):479-95. PubMed ID: 15663345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of oral vitamins and supplements in the management of atopic dermatitis: a systematic review.
    Reynolds KA; Juhasz MLW; Mesinkovska NA
    Int J Dermatol; 2019 Dec; 58(12):1371-1376. PubMed ID: 30892697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complementary/alternative medicine in dermatology: evidence-assessed efficacy of two diseases and two treatments.
    Ernst E; Pittler MH; Stevinson C
    Am J Clin Dermatol; 2002; 3(5):341-8. PubMed ID: 12069640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What's new in atopic eczema? An analysis of systematic reviews published in 2007 and 2008. Part 2. Disease prevention and treatment.
    Williams HC; Grindlay DJ
    Clin Exp Dermatol; 2010 Apr; 35(3):223-7. PubMed ID: 19874342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of Itch in Atopic Dermatitis.
    Pavlis J; Yosipovitch G
    Am J Clin Dermatol; 2018 Jun; 19(3):319-332. PubMed ID: 29285724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How Clinically Relevant Are Treatment Comparisons of Topical Calcineurin Inhibitor Trials for Atopic Eczema?
    Wilkes SR; Nankervis H; Tavernier E; Maruani A; Williams HC
    J Invest Dermatol; 2016 Oct; 136(10):1944-1949. PubMed ID: 27265005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.
    Ashcroft DM; Dimmock P; Garside R; Stein K; Williams HC
    BMJ; 2005 Mar; 330(7490):516. PubMed ID: 15731121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the global resource of eczema trials (GREAT database).
    Nankervis H; Devine A; Williams HC; Ingram JR; Doney E; Delamere F; Smith S; Thomas KS
    BMC Dermatol; 2015 Mar; 15():4. PubMed ID: 25887502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial.
    Mehrbani M; Choopani R; Fekri A; Mehrabani M; Mosaddegh M; Mehrabani M
    J Ethnopharmacol; 2015 Aug; 172():325-32. PubMed ID: 26151244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and Safety of Desoximetasone 0.25% Spray in Adult Atopic Dermatitis Subjects: Pilot Study.
    Hoffman LK; Kircik L
    J Drugs Dermatol; 2017 Sep; 16(9):919-922. PubMed ID: 28915287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.
    Licari A; Ruffinazzi G; DE Filippo M; Castagnoli R; Marseglia A; Agostinis F; Puviani M; Milani M; Marseglia GL
    Minerva Pediatr; 2017 Dec; 69(6):470-475. PubMed ID: 29181960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atopic dermatitis: understanding the disease and its management.
    Levy ML
    Curr Med Res Opin; 2007 Dec; 23(12):3091-103. PubMed ID: 17971284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal Antibodies for Atopic Dermatitis: Progress and Potential.
    Vakharia PP; Silverberg JI
    BioDrugs; 2017 Oct; 31(5):409-422. PubMed ID: 28853008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016.
    Saeki H; Nakahara T; Tanaka A; Kabashima K; Sugaya M; Murota H; Ebihara T; Kataoka Y; Aihara M; Etoh T; Katoh N;
    J Dermatol; 2016 Oct; 43(10):1117-1145. PubMed ID: 27076388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review on the off-label use of montelukast in atopic dermatitis treatment.
    Chin WK; Lee SWH
    Int J Clin Pharm; 2018 Oct; 40(5):963-976. PubMed ID: 29777328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials.
    Betsi GI; Papadavid E; Falagas ME
    Am J Clin Dermatol; 2008; 9(2):93-103. PubMed ID: 18284263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New and emerging targeted systemic therapies: a new era for atopic dermatitis.
    Lee DE; Clark AK; Tran KA; Shi VY
    J Dermatolog Treat; 2018 Jun; 29(4):364-374. PubMed ID: 28853956
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.